REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
04/14/2025
Back to search
Official data from USPTO
BIONDIS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
BIONDIS
ST13
US500000088585565Class
5, 10, 35, 42
Filing
88585565
Registration
6032608
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
32
Latest update
04/15/2025
Trademark type
Word
Nice classes
5, 10, 35, 42
Filing date
08/20/2019
Registration date
04/14/2020
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
04/14/2020
Last transaction
04/15/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
Drawing code
4
Owner type
16
Owner location
6545 CM NIJMEGEN, NL
Examiner
MCCAULEY, BRENDAN
Law office
M50
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
BYONDIS B.V.
Synthon Biopharmaceuticals B.V
Representatives
E. Anthony Figg ROTHWELL FIGG ERNST & MANBECK PC
Technical classification
Nice Classes
Class 5Class 10Class 35Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Biopharmaceutical preparationssubstances and compositionsantibacterial substances for medical purposesmedical diagnostic reagents in the nature of antibody-drug conjugatesimmuno-oncology compounds in the nature of medicinal preparations for the treatment of infectious diseases and for use in oncologycompounds for auto-immune diseasespharmaceutical preparations for the treatment of immune system related diseases and disorders; biopharmaceutical active substancesdiagnostic agentspreparations and substances for medical purposes in the nature of antibody-drug conjugatesimmuno-oncology compoundspharmaceutical preparations and substances for the treatment of oncological related diseases and disorderscompounds for auto-immune diseasespharmaceutical preparations for the treatment of immune system related diseases and disorders; biological and biochemical drug and cultures for medical usebiological preparations for the treatment of cancercultures of microorganisms for medical usebiological tissue cultures for medical purposes; biopharmaceutical active substancesnutritive substances for microorganism cultures; biopharmaceutical components and ingredientsplant and herb extracts sold as components of medicated cosmetics; orthopedic articlesbone repair paste for use in orthopedic surgery; all of the above excluding for the treatment of neuromuscular diseases and disorders
Class 10
Surgical and medical devicesapparatus and instrumentssurgical instruments and apparatussurgical devices and instrumentssurgical apparatus and instrumentsmedical instruments for cutting tissuemedical instrument for performing biopsiesmedical fluid injectorsinjection device for pharmaceuticalssyringes for medical purposesdisposable syringes for medical purposes; orthopedic articlesorthopedic walkersorthopedic supportsorthopedic braces and orthopedic cushions; injection apparatus for medical purposesinjection needles and injection instruments with needles
Class 35
Providing office functions relating to the registration of pharmaceutical preparations and components and pharmaceutical drugs; providing office functions relating to obtaining pharmaceutical registrations and compiling pharmaceutical registration files; business mediation of commercial transactions for othersmediation of contracts for the purchase and sale of productsmediation of agreements all in the field of the purchasesale and licensing of pharmaceutical registrations and pharmaceutical registration files
Class 42
Scientific and technological services and research relating theretoscientific researchanalysis and testing in the fields of antibody-drug conjugatesimmuno-oncology compounds and compounds for auto-immune diseases and scientific research related thereto; scientific and technological services relating to obtaining pharmaceutical registrations and compiling pharmaceutical registration filesscientific research in the field of pharmaceuticals for pharmaceutical registration purposes; pharmaceutical research services and pharmaceutical research consultancy services; biomedical research services and biomedical research consultancy; medical research and medical research consultancy; scientific laboratory services in the fields of chemistry and biologyantibody-drug conjugatesimmuno-oncology compounds and compounds for auto-immune diseases; scientific laboratory services; product development of pharmaceutical products and ingredients for pharmaceuticals; providing information relating to medical and scientific research in the field of pharmaceutical preparations; providing medical and scientific research information regarding the results of clinical trials for pharmaceutical preparations; quality control of products for others to determine conformity with certification standards; laboratory researchscientific and medical research; laboratory analysis in the field of chemistry and biology as related to pharmaceuticals; product research for the pharmaceutical industry; design of pharmaceuticals for the pharmaceutical industry; product research and development for others; drug discovery services; testing in the context of quality controlmaterial testing and product testing; conducting clinical trials for others in the field of pharmaceutical preparations; quality control for others in the field of pharmaceutical preparations; providing information and data relating product research and developments in the pharmaceuticalbiopharmaceutical and medical fields
Publications
History of USPTO decisions and trademark events.
32 publications found
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
11/21/2022
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
11/21/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
11/21/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
11/21/2022
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
05/13/2020
R.PR
REGISTERED-PRINCIPAL REGISTER
04/14/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
01/28/2020
PUBO
PUBLISHED FOR OPPOSITION
01/28/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
01/08/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/19/2019
DOCK
ASSIGNED TO EXAMINER
12/12/2019
XAEC
EXAMINER'S AMENDMENT ENTERED
12/11/2019
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
12/11/2019
GNEA
EXAMINERS AMENDMENT E-MAILED
12/11/2019
CNEA
EXAMINERS AMENDMENT -WRITTEN
12/11/2019
DOCK
ASSIGNED TO EXAMINER
12/11/2019
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
12/09/2019
GNRT
NON-FINAL ACTION E-MAILED
12/09/2019
CNRT
NON-FINAL ACTION WRITTEN
12/09/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/02/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/02/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
11/29/2019
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
11/20/2019
GNRT
NON-FINAL ACTION E-MAILED
11/20/2019
CNRT
NON-FINAL ACTION WRITTEN
11/20/2019
DOCK
ASSIGNED TO EXAMINER
11/19/2019
AMPX
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
11/05/2019
ALIE
ASSIGNED TO LIE
10/31/2019
PARI
TEAS VOLUNTARY AMENDMENT RECEIVED
10/25/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/05/2019
NWAP
NEW APPLICATION ENTERED
08/23/2019
Continuous trademark protection
Get notified about every new filing that threatens BIONDIS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.